Archives

CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis

B CAPLYTA® ranked highest among FDA-approved adjunctive therapies across four measures of efficacy, based on indirect comparisons from placebo plus antidepressant therapy-controlled trials Among the… Login to continue reading Login…

Read MoreCAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis

Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors’ Microbiome Evaluation at ESCMID Global 2026

B DNA pol IIIC inhibitors demonstrate the unexpected benefit of gut microbiome preservation while demonstrating systemic antibacterial activity Neutropenic CD-1 mice were infected intramuscularly with… Login to continue reading Login…

Read MoreAcurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors’ Microbiome Evaluation at ESCMID Global 2026

Powering Progress: The Melanoma Research Alliance Announces $18.4 Million Global Research Investment to Accelerate the Next Era of Melanoma Breakthroughs

B WASHINGTON, May 4, 2026 /PRNewswire/ — The Melanoma Research Alliance (MRA), the world’s leading non-profit funder of melanoma research, announced its largest annual global… Login to continue reading Login…

Read MorePowering Progress: The Melanoma Research Alliance Announces $18.4 Million Global Research Investment to Accelerate the Next Era of Melanoma Breakthroughs

New York Jets Complete Historic Inaugural Season of Nation’s Largest Collegiate Women’s Flag Football League, with Marymount Hoisting “The Betty”

B After nearly 100 games played across seven states, the Jets and ECAC laid the foundation for future expansion while creating new pathways for young… Login to continue reading Login…

Read MoreNew York Jets Complete Historic Inaugural Season of Nation’s Largest Collegiate Women’s Flag Football League, with Marymount Hoisting “The Betty”